Literature DB >> 23573322

Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype.

Tadashi Terada1.   

Abstract

In the current WHO blue book, combined hepatocellular-cholangiocarcinoma (C-HCC-CC) was classified into two types; classical type and type with stem cell features. The latter is extremely rare, and is subcategorized into the following three subtypes; typical subtype, intermediate cell subtype, and cholangiocellular subtype. Recently, intrahepatic cholangiocarcinoma (ICC) with features of ductal plate malformations (DPM) have been reported, and the ICC with DPM was proposed as a subtype of ICC. The author herein reports a case of C-HCC-CC with stem cell features. Characteristically, the CC element showed features of DPM. A 51-year-old man of HBV carrier was found to have high AFP. A laboratory test showed an elevated AFP (395 ng/ml, normal 9-10) and hepatitis B virus-related antigens and antibodies. Liver and ductal enzymes and PIVKAII were within normal ranges. Imaging modalities including CT identified a small liver tumor. Hepatocellular carcinoma (HCC) was suspected, and the resection of the hepatic tumor was performed. Grossly, the liver tumor is well-defined white solid tumor measuring 22x16x23 mm. Microscopically, the tumor was a C-HCC-CC, and was composed of following three elements: well differentiated HCC, well differentiated cholangiocarcinoma (CC), and intermediate tumor element. Characteristically, the CC cells formed tortuous markedly irregular tubules with intraluminal cell projections, bridge formations, intraluminal tumor biliary cells; such features very resembled the ductal plate (DP) and DPM. Immunohistochemically, the cells of CC element were positive for stem cell antigens (KIT (CD117), CD56, EMA, CD34), HepPar1, EpCAM, cytokeratin (CK) CAM5.2, AE1/3, CK34BE12 (focal), CK7, CK8, CK18, CK19, CA19-9, p53, MUC1, MUC2, MUC5AC, MUC6, and Ki-67 (labeling=25%). They were negative for CEA, CK5/6, CK20, NSE, chromogranin, synaptophysin, and p63. No mucins were found by histochemically. The background liver showed chronic hepatitis B (a1, f3). Very interestingly, many DPMs were scattered in the non-tumorous parenchyma. This type of C-HCC-CC with DPM features has not been reported. The author herein proposes that this tumor should be included or added in the C-HCC-CC subtype as C-HCC-CC with stem cell features, DMP subtype.

Entities:  

Keywords:  Combined hepatocellular cholangiocarcinoma; ductal plate; ductal plate malformation; histopathology; immunohistochemistry; liver stem cells

Mesh:

Substances:

Year:  2013        PMID: 23573322      PMCID: PMC3606865     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  77 in total

Review 1.  Ductal plates in hepatic ductular reactions. Hypothesis and implications. I. Types of ductular reaction reconsidered.

Authors:  Valeer J Desmet
Journal:  Virchows Arch       Date:  2011-02-02       Impact factor: 4.064

2.  Development of human intrahepatic peribiliary glands. Histological, keratin immunohistochemical, and mucus histochemical analyses.

Authors:  T Terada; Y Nakanuma
Journal:  Lab Invest       Date:  1993-03       Impact factor: 5.662

3.  A new set of classifications for ductal plate malformations.

Authors:  Stacey S Huppert
Journal:  Hepatology       Date:  2011-06       Impact factor: 17.425

4.  Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice.

Authors:  Regina Español-Suñer; Rodolphe Carpentier; Noémi Van Hul; Vanessa Legry; Younes Achouri; Sabine Cordi; Patrick Jacquemin; Frédéric Lemaigre; Isabelle A Leclercq
Journal:  Gastroenterology       Date:  2012-08-21       Impact factor: 22.682

5.  Divergent expression of midkine in the human fetal liver and kidney: immunohistochemical analysis of developmental changes in hilar primitive bile ducts and hepatocytes.

Authors:  M Kato; T Shinozawa; S Kato; T Terada
Journal:  Liver       Date:  2000-12

Review 6.  Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma.

Authors:  S Sell; H A Dunsford
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

7.  Monolobar ductal plate malformation disease of the liver.

Authors:  Tadashi Terada; Toshiaki Moriki
Journal:  Pathol Int       Date:  2010-05       Impact factor: 2.534

8.  Congenital biliary dilatation in autosomal dominant adult polycystic disease of the liver and kidneys.

Authors:  T Terada; Y Nakanuma
Journal:  Arch Pathol Lab Med       Date:  1988-11       Impact factor: 5.534

9.  Intrahepatic cholangiographic appearance simulating primary sclerosing cholangitis in several hepatobiliary diseases: a postmortem cholangiographic and histopathological study in 154 livers at autopsy.

Authors:  T Terada; Y Nakanuma
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

10.  Identification of bipotential progenitor cells in human liver development.

Authors:  Y Haruna; K Saito; S Spaulding; M A Nalesnik; M A Gerber
Journal:  Hepatology       Date:  1996-03       Impact factor: 17.425

View more
  12 in total

1.  Hepatobiliary cystadenocarcinoma of the liver with features of ductal plate malformations.

Authors:  Tadashi Terada
Journal:  J Gastrointest Cancer       Date:  2015-06

Review 2.  Histopathology of hepatocellular carcinoma.

Authors:  Manuel Schlageter; Luigi Maria Terracciano; Salvatore D'Angelo; Paolo Sorrentino
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  Intrahepatic cholangiocarcinoma with predominant ductal plate malformation pattern.

Authors:  Ji-Young Choe; Haeryoung Kim
Journal:  Clin Mol Hepatol       Date:  2014-06

Review 4.  Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.

Authors:  An-Qiang Wang; Yong-Chang Zheng; Juan Du; Cheng-Pei Zhu; Han-Chun Huang; Shan-Shan Wang; Liang-Cai Wu; Xue-Shuai Wan; Hao-Hai Zhang; Ruo-Yu Miao; Xin-Ting Sang; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

Review 5.  Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.

Authors:  Alphonse E Sirica; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Adv Cancer Res       Date:  2020-12-09       Impact factor: 6.242

Review 6.  Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.

Authors:  Maurizio Romano; Francesco De Francesco; Giuseppe Pirozzi; Enrico Gringeri; Riccardo Boetto; Marina Di Domenico; Barbara Zavan; Giuseppe A Ferraro; Umberto Cillo
Journal:  Oncoscience       Date:  2015-05-15

Review 7.  Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.

Authors:  Ijin Joo; Haeryoung Kim; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

8.  LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours.

Authors:  Anthony J Scarzello; Qun Jiang; Timothy Back; Hien Dang; Deborah Hodge; Charlotte Hanson; Jeffrey Subleski; Jonathan M Weiss; Jimmy K Stauffer; Jitti Chaisaingmongkol; Siritida Rabibhadana; Mathuros Ruchirawat; John Ortaldo; Xin Wei Wang; Paula S Norris; Carl F Ware; Robert H Wiltrout
Journal:  Gut       Date:  2015-07-23       Impact factor: 23.059

9.  Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation-like Feature Associated with Bile Duct Adenoma.

Authors:  Ah-Young Kwon; Hye Jin Lee; Hee Jung An; Haeyoun Kang; Jin-Hyung Heo; Gwangil Kim
Journal:  J Pathol Transl Med       Date:  2015-07-31

10.  Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma.

Authors:  Zhiyu Li; Xiaolong Wu; Xinyu Bi; Yefan Zhang; Zhen Huang; Haizhen Lu; Hong Zhao; Jianjun Zhao; Jianguo Zhou; Muxing Li; Jianming Ying; Jianqiang Cai
Journal:  Chin J Cancer Res       Date:  2018-06       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.